Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1979 Aug;40(2):228–233. doi: 10.1038/bjc.1979.170

Evidence that cells from experimental tumours can activate coagulation factor X.

L Curatolo, M Colucci, A L Cambini, A Poggi, L Morasca, M B Donati, N Semeraro
PMCID: PMC2010022  PMID: 573131

Abstract

The procoagulant activity of cells from some experimental tumours isolated in culture or in single-cell suspensions from ascitic fluid was investigated. Cells from Lewis lung carcinoma (primary and metastasis), Ehrlich carcinoma ascites and JW sarcoma ascites were able to shorten markedly the recalcification time of normal, Factor VIII- and Factor VII-deficient but not of Factor X-deficient human plasma. The same cells generated thrombin when mixed with a source of prothrombin and Factor X, absorbed bovine serum (as a source of Factor V), phospholipid and calcium chloride. Thrombin formation was not influenced by the presence of Factor VII. Cells from Sarcoma 180 ascites were completely inactive in both test systems. It is concluded that cells from some experimental tumours have the capacity to activate Coagulation Factor X directly. These findings suggest the existence of an alternative "cellular" pathway in the initiation of blood clotting distinct from both the intrinsic and extrinsic mechanisms.

Full text

PDF
228

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Frindel E., Malaise E. P., Alpen E., Tubiana M. Kinetics of cell proliferation of an experimental tumor. Cancer Res. 1967 Jun;27(6):1122–1131. [PubMed] [Google Scholar]
  2. HIRAMOTO R., BERNECKY J., JURANDOWSKI J., PRESSMAN D. Fibrin in human tumors. Cancer Res. 1960 Jun;20:592–593. [PubMed] [Google Scholar]
  3. Holyoke E. D., Frank A. L., Weiss L. Tumor thromboplastic activity in vitro. Int J Cancer. 1972 Mar 15;9(2):258–263. doi: 10.1002/ijc.2910090203. [DOI] [PubMed] [Google Scholar]
  4. Janik P. Lung colony assay in normal, irradiated and tumor bearing mice. Neoplasma. 1976;23(5):495–497. [PubMed] [Google Scholar]
  5. O'MEARA R. A. Coagulative properties of cancers. Ir J Med Sci. 1958 Oct;394:474–479. [PubMed] [Google Scholar]
  6. Ogura T., Tsubura E., Yamamura Y. Localization of radioiodinated fibrinogen in invaded and metastasized tumor tissue of Walker carcinosarcoma. Gan. 1970 Oct;61(5):443–449. [PubMed] [Google Scholar]
  7. Peterson H. Fibrinolysis and antifibrinolytic drugs in the growth and spread of tumours. Cancer Treat Rev. 1977 Sep;4(3):213–217. doi: 10.1016/s0305-7372(77)80025-x. [DOI] [PubMed] [Google Scholar]
  8. Pineo G. F., Brain M. C., Gallus A. S., Hirsh J., Hatton M. W., Regoeczi E. Tumors, mucus production, and hypercoagulability. Ann N Y Acad Sci. 1974;230:262–270. doi: 10.1111/j.1749-6632.1974.tb14458.x. [DOI] [PubMed] [Google Scholar]
  9. Pineo G. F., Regoeczi E., Hatton M. W., Brain M. C. The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas. J Lab Clin Med. 1973 Aug;82(2):255–266. [PubMed] [Google Scholar]
  10. Poggi A., Polentarutti N., Benedetta Donati M., de Gaetano G., Garattini S. Blood coagulation changes in mice bearing Lewis lung carcinoma, a metastasizing tumor. Cancer Res. 1977 Jan;37(1):272–277. [PubMed] [Google Scholar]
  11. Sakuragawa N., Takahashi K., Hoshiyama M., Jimbo C., Ashizawa K. The extract from the tissue of gastric cancer as procoagulant in disseminated intravascular coagulation syndrome. Thromb Res. 1977 Mar;10(3):457–463. doi: 10.1016/0049-3848(77)90155-4. [DOI] [PubMed] [Google Scholar]
  12. Semeraro N., Colucci M., Vermylen J. Complement-dependent and complement-independent interactions of bacterial lipopolysaccharides and mucopeptides with rabbit and human platelets. Thromb Haemost. 1979 Apr 23;41(2):392–406. [PubMed] [Google Scholar]
  13. Semeraro N., Vermylen J. Evidence that washed human platelets possess factor-X activator activity. Br J Haematol. 1977 May;36(1):107–115. doi: 10.1111/j.1365-2141.1977.tb05760.x. [DOI] [PubMed] [Google Scholar]
  14. Simpson-Herren L., Sanford A. H., Holmquist J. P. Cell population kinetics of transplanted and metastatic Lewis lung carcinoma. Cell Tissue Kinet. 1974 Jul;7(4):349–361. doi: 10.1111/j.1365-2184.1974.tb00417.x. [DOI] [PubMed] [Google Scholar]
  15. Slichter S. J., Harker L. A. Hemostasis in malignancy. Ann N Y Acad Sci. 1974;230:252–261. doi: 10.1111/j.1749-6632.1974.tb14457.x. [DOI] [PubMed] [Google Scholar]
  16. Svanberg L. Thromboplastic activity of human ovarian tumours. Thromb Res. 1975 Apr;6(4):307–313. doi: 10.1016/0049-3848(75)90080-8. [DOI] [PubMed] [Google Scholar]
  17. Tannock I. F. A comparison of cell proliferation parameters in solid and ascites Ehrlich tumors. Cancer Res. 1969 Aug;29(8):1527–1534. [PubMed] [Google Scholar]
  18. Tremoli E., Donati M. B., de Gaetano G. Washed guinea-pig and rat platelets possess factor-X activator activity. Br J Haematol. 1977 Sep;37(1):155–156. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES